EPISODE · May 26, 2026 · 7 MIN
SHTG Digest — Tuesday May 26, 2026
from SHTG Daily Digest — Weiss Lab
A landmark Circulation imaging trial finds that olezarsen's dramatic triglyceride lowering does not translate into coronary plaque regression at 12 months—raising fundamental questions about TG-lowering as an atherosclerosis therapy just as the 2026 ACC/AHA dyslipidemia guideline reframes how we should think about hypertriglyceridemia, and with Ionis's PDUFA date for the SHTG indication just five weeks away.
Embed this episode
Ready to play
SHTG Digest — Tuesday May 26, 2026
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.